Royalty Report: Medical, Device, Personal Care Products – Collection: 246730

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 11

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 11

Primary Industries

  • Medical
  • Device
  • Personal Care Products
  • Dermatology
  • Surgical
  • Therapeutic
  • Scientific & Technical Instruments
  • Skin care

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 246730

License Grant
As a center for research and education, Hospital is interested in licensing additional Patent rights and Photon Recycling Patent Rights and Licensee having such capacity, desires to commercially develop, manufacture, use and distribute such products throughout the world, the Hospital and Licensee hereby agree to amend the License Agreement and all references in the License Agreement shall be deemed to be references to such License Agreement as amended hereby to include

a) an exclusive, worldwide, royalty-bearing license in all fields under Hospital’s rights in additional Patent Rights to make, have made, use and sell products and to perform services; and
b) a non-exclusive, worldwide, perpetual, irrevocable, fully paid up license in all fields under Hospital’s rights in Photon Recycling Patent Rights to make, have made, use and sell products and to perform services.

License Property
The product consists of the SLP1000 Diode Laser System and associated hand pieces (“SLP1000”) and the EsteLux Pulsed-Light System and associated hand pieces (“EsteLux”) for hair removal and other applications.

The term Photon Recycling Patent Rights shall mean Hospital’s rights in U.S. Patent No. 5,824,023, filed April 16, 1996 and entitled “Radiation-Delivery Device”, including any division, continuation or any foreign patent application or Letters Patent or the equivalent thereof issuing thereon or reissue, reexamination or extension thereof. Photon Recycling Patent Rights shall also include those claims in any continuation-in-part which claims an invention described or claimed in U.S. Patent No. 5,824,023.

The term Additional Patent Rights shall mean Hospitals rights in
(i) U.S. Patent Number 6,273,884 issued August 14, 2001 and entitled 'Method and Apparatus for Dermatology Treatment'
(ii) U.S. Patent Number 6,511,475 issued January 28, 2003 and entitled 'Heads for Dermatology Treatment' (CIP off 6,273,884)
(iii) Utility Patent Application Serial Number 10/274,582, filed October 21, 2002 and entitled 'Heads for Dermatology Treatment' (divisional off 6,511,475)
(iv) Utility Patent Application Serial Number 09/277,307 filed March 26, 1999 and entitled 'Method and Apparatus for the Selective Targeting of Lipid-Rich
Tissues'
(v) Utility Patent Application Serial Number 09/769,960 filed January 25, 2001 and entitled 'Method and Apparatus for EMR Treatment'
(vi) Utility Patent Application Serial Number 10/033,302 filed December 27, 2001 and entitled 'Method and Apparatus for EMR Treatment'
(vii) Provisional Patent Application Serial Number 60/363,871 filed March 12, 2002 and entitled 'Method and Apparatus for Hair Growth Control'
(viii) Provisional Patent Application Serial Number 60/389,871 filed June 19, 2002 and entitled 'Method of Selectively Heating Subcutaneous Fat', and any other divisional or continuation patent applications naming one or more Hospital employees as inventors to the extent the aforementioned are jointly owned with Licensee.

Field of Use
The Licensee splits its efforts between new products for existing markets such as the removal of unwanted hair, vascular and pigmented lesions and tattoos, and new products for markets, such as acne treatment, fat reduction and wrinkle removal.

IPSCIO Record ID: 66606

License Grant
Hospital hereby grants to Company in the License Field in the License Territory for the License Term
(i)an exclusive, royalty-bearing license under Patent Rights to research, develop, make, have made, use, have used, sell, offer to sell, have sold, and Transfer the Products and to research, develop, use, have used, otherwise practice and have practiced and Transfer the Processes.
License Property
The patent and the core technology underlies the CoolSculpting system.

Patents under First License
1. US Utility Patent Application, Serial No. 10/391,221, filed on March 17th, 2003, claiming priority from US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.
2. US Utility Patent Application, Serial No. 11/016,196, filed on December 17th, 2003, a continuation in part of US Utility Patent Application, Serial No 10/391,221
3. PCT Patent Application, Serial No. US03/08014, filed on March 17, 2003.

Field of Use
'License Field' shall mean the controlled use of cold for any therapy or procedure directed to treatment of acne vulgaris, acne cystica, milia, sebaceous hyperplasia, steatocystoma multiplex, Favre-Racouchot, rosacea, hidradenitis supprativa, and/or folliculitis.

IPSCIO Record ID: 28590

License Grant
Hospital hereby grants to Company the following

(i) an exclusive, royalty-bearing license under patent rights to make, have made, use, have used, sell, offer to sell, have sold, and Transfer Products and to use, have used, otherwise practice and have practiced and Transfer Processes;

(ii) the nonexclusive right to disclose, use and Transfer Technology IinformationTechnological Information disclosed by Hospital to Company hereunder; and

(iii) the right to grant sublicenses under the rights granted in Section 2.l(a)(i) and 2.1(a)(ii) to Sublicensees, provided that in each case Compny shall be responsible for the performance of any obligations of Sublicensees relevant to this Agreement as if such performance were carded out by Company itself, including, without limitation, the payment of any royalties or other payments provided for hereunder, regardless of whether the terms of any sublicense provide for such amounts to be paid by the Sublicensee directly to Hospital.

License Property
This product has achieved FDA clearance, to market CoolSculpting, for the selective reduction of fat.

The Licensee is a medical technology company focused on developing and commercializing products utilizing our proprietary controlled-cooling technology platform.

Our first commercial product, the CoolSculpting System, selectively reduces stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

CoolSculpting utilizes precisely controlled cooling to reduce the temperature of fat cells in the treated area, which leads to fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. Our clinical studies demonstrate that a single CoolSculpting procedure safely, noticeably, and measurably reduces the fat layer within a treated fat bulge without requiring the patient to diet or exercise.

PATENT RIGHTS
1. US Utility Patent Application, Serial No- 10/391,221, filed on March 17th, 2003, claiming priority From US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.
2. US Utility Patent Application, Serial No. 11/016,196, filed on December 17th, 2003, a continuation in part of US Utility Patent Application, Serial No 10/391,221.
3. PCT Patent Application, Serial No. US03/08014, filed on March 17, 2003.
4. Australia Patent Application No 2003220311, claiming priority from PCT Patent Application No. PCT/US03/08014, tiled on March 17th, 2003.
5. Brazil Patent Application No, 0308642.9, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
6. Canada Patent Application No. 2,478,887, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
7. China Patent Application No, 03810938.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
8. Israel Patent Application No. 164115, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on March 17th, 2003.
9. Japan Patent Application No. 2003-576590, claiming priority from PCT Patent Application No PCT/US03/08014, filed on March 17th, 2003.
10. Mexico Patent Application No. 2004-008992, claiming priority from PCT Patent Application No PCT/US03/08014, filed on March 17th, 2003.
11. EPO Patent Application No. 03711609.7, claiming priority from PCT Patent Application No, PCT/US03/08014, filed on March 17th, 2003.

Field of Use
“LICENSE FIELD” shall mean removal of cutaneous, subcutaneous or subdermal fat, treatment or removal of cellulite, and any therapy or procedures (including without limitation aesthetic therapies or procedures) to the tissues and structures of the skin (including without limitation sweat glands and hair follicles), subcutaneous tissue, and tumors, lesions and adipose tissue of the skin and of subdermal tissue.bb

IPSCIO Record ID: 28030

License Grant
HOSPITAL hereby grants to COMPANY in the LICENSE FIELD in the LICENSE TERRITORY for the LICENSE TERM
  (i) an exclusive, royalty-bearing license under PATENT RIGHTS to make, have made, use, have used, sell, offer to sell, have sold, and TRANSFER PRODUCTS and to use, have used, otherwise practice and have practiced and TRANSFER PROCESSES;

  (ii) the nonexclusive right to disclose, use and transfer TECHNOLOGICAL INFORMATION disclosed by HOSPITAL to COMPANY hereunder; and

  (iii) the right to grant sublicenses under the rights granted.

License Property
This product has achieved FDA clearance, to market CoolSculpting, for the selective reduction of fat.

The Licensee is a medical technology company focused on developing and commercializing products utilizing the proprietary controlled-cooling technology platform.

The first commercial product, the CoolSculpting System, selectively reduces stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues.

CoolSculpting utilizes precisely controlled cooling to reduce the temperature of fat cells in the treated area, which leads to fat cell elimination through a natural biological process known as apoptosis, without causing scar tissue or damage to the skin, nerves, or surrounding tissues. Our clinical studies demonstrate that a single CoolSculpting procedure safely, noticeably, and measurably reduces the fat layer within a treated fat bulge without requiring the patient to diet or exercise.

PATENT RIGHTS  1. US Utility Patent Application, Serial
No. 10/391,221, filed on March 17th, 2003,
claiming priority from US Provisional Application, Serial No. 60/365,662, filed on March 15th, 2003.  2. US Utility Patent Application, Serial No. 11/016,196, filed
on December 17th, 2003, a continuation in part of US
Utility Patent Application, Serial No 10/391,221.  3. PCT Patent Application, Serial No. US03/08014, filed on March 17, 2003.
4. Australia Patent Application No. 2003220311, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
5. Brazil Patent Application No. 0308642.9, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
6. Canada Patent Application No. 2,478,887, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
7. China Patent Application No. 03810938.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
8. Israel Patent Application No. 164115, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
9. Japan Patent Application No. 2003-576590, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
10. Mexico Patent Application No. 2004-008992, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.
11. EPO Patent Application No. 03711609.7, claiming priority from PCT Patent Application No. PCT/US03/08014, filed on
March 17th, 2003.

Field of Use
License Field shall mean removal of cutaneous, subcutaneous or subdermal fat, treatment or removal of cellulite, andany therapy or procedures (including without limitation aesthetic therapies or procedures) to the tissues and structures of the skin (including without limitation sweat glands and hair follicles), subcutaneous tissue, and tumors, lesions and adipose tissue of the skin and of subdermal tissue

The Licensee shall itself or through an Affiliate or sublicensee make a first commercial sale within the following countries and regions within the following number years after the effective date of the Agreement
United States of America – Six years
Japan – Seven years
Latin America – Seven years
EPO – Seven years

IPSCIO Record ID: 329716

License Grant
Hospital hereby grants Licensee and its affiliates (subject to the rights of the United States Government, if any) (a) an exclusive, worldwide, royalty-bearing, transferable (to the extent permitted in Agreement) license in the license field under Hospital’s rights in Patent Rights to make, have made, use, import, sell and offer for sale products and to use, perform, sell and offer for sale services; and (b) the right to sublicense the Patent Rights exclusively licensed under this agreement.
License Property
U.S. Patent Numbers
6,273,884 – Method and apparatus for dermatology treatment
6,511,475 – Heads for dermatology treatment
7,077,840 – Heads for dermatology treatment
Field of Use
License Field shall mean dermatologic treatment using optical radiation.

IPSCIO Record ID: 27330

License Grant
The Company, a not-for-profit  corporation, hereby grants an exclusive, worldwide license to the patented invention pertaining to the use of lasers for hair removal.
License Property
The term 'PATENT RIGHT' shall mean the U.S. Patent Application filed by Dr.Anderson, et.al. on February 1, 1995 entitled 'Permanent Hair Removal Using Optical Pulses,' or the equivalent of such application, including any division, continuation or any foreign patent application or Letters Patent or the equivalent thereof issuing thereon or reissue, reexamination or extension thereof.

IPSCIO Record ID: 28651

License Grant
Assignors, two individuals, hereby sell, assign, and transfer exclusively and subject to all of the terms and conditions of this Agreement, their entire right, title, and interest in and to the Device and the Intellectual Property.
License Property
“Applications” shall mean any and all pending patent applications filed by Assignors relating to the Device and any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure designed or used by Assignors, including, but not limited to, the following
(a) In the United States, application No. 09/733,224 entitled Annuloplasty System, filed December 8, 2000;
(b) In Canada, application No. 2,197,069 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995;
(c) In the European Region, application No. 95929486.9 entitled Apparatus for Reducing the Circumference of a Vascular Structure, filed August 10, 1995; and
(d) In Japan, application No. 507532/1996 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995 and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which either Segmed or Dr. Northrup is an inventor, which relate to the Device and/or any apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom; and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by either or both of the Assignors, and any patent applications therefor and any patents issuing therefrom.

“Device” shall mean the apparatus and/or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure (the “Field”) covered by the Intellectual Property and fully described in the Applications and applications relating to the Patents, and any and all improvements, modifications, derivations, enhancements, technology, Know-how and Documentation related thereto.

Patent relates to a new annuloplasty technology for the repair of mitral and tricuspid heart valves.

“Patents” shall mean the following patents issued to Assignors in the United States, Australia, Taiwan and South Africa
(a) In the United States, U.S. Patent No. 5,593,424 entitled Apparatus and Method for Reducing and Stabilizing the Circumference of a Vascular Structure, issued January 14, 1997, U.S. Patent No. 5,709,695 entitled Apparatus for Reducing the Circumference of a Vascular Structure, issued January 20, 1998, and U.S. Patent No. 5,961,539 entitled Method and Apparatus for Sizing, Stabilizing and/or Reducing the Circumference of an Anatomical Structure, issued October 5, 1999;
(b) In Australia, patent No. 700530 entitled Apparatus for Reducing Circumference of Vascular Structure, filed August 10, 1995;
(c) In Taiwan, patent No. 096871 entitled Apparatus for Reducing the Circumference of a Bodily Structure, filed August 11, 1995; and
(d) In South Africa patent No. 95/6672 entitled Apparatus and Method for Reducing the Circumference of a Vascular Structure, filed August 10, 1995,
and any and all patents and/or patent applications claiming priority thereto, and any and all patents or patent applications in which Assignors are an inventor, which relate to the Device and/or any apparatus or method for reducing, sizing and/or stabilizing the circumference of a vascular or anatomical structure, and any reissues, continuations, divisions, continuations-in-part or extensions thereof, any patents issuing therefrom, and/or any improvements thereto or enhancements thereof which are either wholly or in part owned, invented, controlled, acquired or otherwise assignable by Assignors, and any patent applications therefor and any patents issuing therefrom.

“Trademark” shall mean the mark represented by United States Registration No. 2,108,883 for the “SEGMENT” mark.

IPSCIO Record ID: 25834

License Grant
The Licensor hereby grants to Licensee a worldwide, royalty-bearing, non-exclusive sublicense, under the Anderson Patents to make, use, sell, offer for sale and import Licensed Products.
License Property
Licensed Products shall mean Laserscope Products including those Laserscope Hair Modules that alone amount to a Laserscope Product.

Laserscope Hair Module shall mean any energy source module, sold by Laserscope or Laserscope Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation to remove hair.

Laserscope Other Module shall mean any energy source module, sold by Laserscope or Laserscope Affiliates, that is marketed as being capable of using or uses or is incorporated into a product or system that uses optical radiation for the treatment of skin including treatment of vascular and pigmented lesions, acne, fat, cellulite, wrinkles, scars and tattoos, skin tightening, and for other dermatological applications.

The Anderson Patents include patents 5,595,568 & 5,735,844, 5,824,023.

Field of Use
Field shall mean the field in which products or systems are intended for or marketed to consumers for personal use.

IPSCIO Record ID: 240626

License Grant
The Hospital and Licensee hereby agree to amend the License Agreement pertaining to sublicensing and all references in the License Agreement shall be deemed to be references to such License Agreement as amended hereby. Notwithstanding the foregoing, nothing in this Amendment is intended to alter in any way the resolution reached between Licensee and Hospital of the issues arising from the 1999 royalty audit of License by Hospital.
License Property
The product consists of a non-ruby laser that is sold for both hair removal and leg vein treatment (Lightsheer Diode Laser).

U.S. Patent No. 5,824,023

Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 3030

License Grant
Licensor, the son of  the original founder of Licensee, hereby assign and grant to Licensee for the TERM and subject to the provisions of this Agreement, with right to grant licenses to third parties consistent with the terms of this Agreement, all of the INVENTORS' right, title and interest worldwide in and to (a) the INVENTIONS, and (b) the SUBJECT PATENTS.
License Property
INVENTORS have invented and are the sole owners of an INVENTION relating to an apparatus and method for removing HIV and other viruses from the blood.

Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. Most recently, we discovered our Hemopurifier® effectively captures tumor-secreted exosomes, known to kill off the immune cells of those afflicted with cancer.

An application for a provisional patent was filed by INVENTORS on August 31, 1998 with the United States Patent and Trademark Office under serial number 60/098,477 with respect to such INVENTION, and US utility application Serial No. 09/385166 and International Application No. PCT/US 99-19448 were filed by INVENTORS with respect to such INVENTION.

Field of Use
'FIELD OF USE' shall mean devices and methods for removing HIV and other viruses from the blood employing a filtration device having antibodies and/or DNA fragments immobilized on a material and retained by a membrane that allows serum containing virus to interact with the antibodies and/or DNA, including but not limited to such devices and methods as described in SUBJECT PATENTS.

IPSCIO Record ID: 203491

License Grant
The University hereby grants to the Licensee a co-exclusive license (with New Star) to the Regents Patent Rights, for the following fields of use (i) for procedures that involve non-ablative laser skin rejuvenation including collagen formation, collagen remodeling, skin smoothing and wrinkle treatment, (ii) for procedures that involve the treatment of facial and lower extremities telangiestasias and spider veins and (iii) for procedures using a long pulse [0.2 – 500 milliseconds] 1.06 UM Nd.YAG laser (collectively, the 'Co-exclusive Fields of Use') and grants to the Licensee an exclusive license to the Regents Patent Rights for the following fields of use for procedures that involve (i) vascular skin lesions and (ii) laser hair removal (collectively, the 'Exclusive Fields of Use'), to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method. The Regents hereby grants to Licensee a non-exclusive license under The Regents Patent Rights to make, have made, use, sell, offer for sale, and import Patent Products and to practice the Patent Method in any fields of use not covered by the Co-exclusive Fields of Use and the Exclusive Fields of Use. The Regents specifically retains all rights to grant Further Licenses to The Regents Patent Rights to any party for fields of use not covered by the Co-Exclusive Fields of Use and the Exclusive Fields of Use.

This Agreement grants the exclusive right, co-exclusive right, or nonexclusive right to use or sell the Patent Products in the United States within specified fields of use, Licensee agrees that any Patent Products embodying the Regents Patent Rights or produced through the use thereof will be manufactured substantially in the United States.

License Property
Regents Patent Rights means all U.S. patents and patent applications and foreign patents and patent  applications assigned to The Regents, including any reissues, extensions, substitutions, continuations, divisions and continuations-in-part (only to the extent, however, that claims in any continuations-in-part not listed below are entitled to the priority filing date of any of the below listed patents and patent applications) based on and including any subject matter claimed in or covered in U.S. Patent Application Serial Number 08/222,976 entitled 'Apparatus and Method for Dynamic Cooling of Biological Tissues for Thermal Mediated Surgery' now  abandoned; filed April 5, 1994; and assigned to The Regents. As of the effective date of this Agreement, the Regents Patent Rights include the following patents and patent applications
93-364-2            08/441930                                US    5,814,040 issued 09/29/98
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery
93-364-3            08/870467                                US   5,979,454 issued 11/09/99
Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
93-364-4            08/963531                                US   6,171,301 B1 issued 01/09/01
Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery

Patent Products means any kit, composition of matter, material, or product whose manufacture, use, or sale in a particular country would infringe, but for the license granted to Licensee pursuant to this Agreement, an unexpired Claim of a patent or pending claim of a patent application under Regents Patent Rights in that country in which such patent has issued or application is pending; any kit, composition of matter, material, or product to be used in a manner requiring the performance of the Patent Method; or any kit, composition of matter, material, or product produced by the Patent Method. This definition of Patent Products also includes a service either used by Licensee or provided by Licensee to its customers when such service requires the practice of the Patent Method. Dynamic Cooling Device (or DCD) means a cooling device for use with a laser system, the combination of which utilizes the Regents Patent Rights. DCDs, whether sold as (i) an accessory or upgrade product to a laser system or (ii) integrated with a laser system as one product, are Patent Products.

Field of Use
Dynamic Cooling Device (DCD) is a device which cools the top layer of the skin, while leaving the targeted underlying hair follicle, vein or other structure at normal temperature. As a result, higher levels of laser energy can be delivered during treatment, while minimizing thermal injury, pain, and the inconvenience associated with anesthetics. The design of the hand-held DCD enables the practitioner to clearly see the area being treated, and the combined efficiency of the lasers and DCD reduces the risks of over treatment. The DCD delivers the appropriate amount of cooling quickly and consistently.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.